Vigabatrin Tablet, Film Coated
Product Images NDC 70771-1654

4 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70771-1654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 01)

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 01)
Chemical structure of vigabatrin, showing its molecular arrangement with functional groups and bonds clearly depicted.*
FDA Label Image

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 02)

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 02)
A line graph showing percentage reduction in seizure frequency versus percentage of patients for vigabatrin (VGB) at daily doses of 1g, 3g, and 6g compared to placebo. The vertical axis represents change in seizure frequency with improvement and worsening indicated, while the horizontal axis shows cumulative percentage of patients. Different lines correspond to varying VGB dosages and placebo.*
FDA Label Image

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 03)

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 03)
A cumulative distribution plot showing percentage reduction in seizure frequency on the vertical axis versus percentage of patients on the horizontal axis. The graph compares two lines representing placebo and 3g/day vigabatrin (VGB), with annotations indicating improvement, no change, and worsening of seizure frequency.*
FDA Label Image

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 04)

Image (214b2d85 342a 4bf6 Bd69 D0f46feb2af7 04)
Vigabatrin Tablets, USP 500 mg film-coated tablets package label. The label includes the product name, strength, quantity of 100 tablets, and prescription-only status. It provides storage instructions, dispenser guidance for pharmacists, and child-resistant packaging information. The labeler is Zydus Lifesciences Limited, Ahmedabad, India. The NDC number 70771-1654-1 and barcode are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.